Omid Farokhzad Seer, Inc. (SEER) insider trading activity

SEER Quotes by TradingView

Omid Farokhzad is CEO AND CHAIR of Seer, Inc.. Currently has a direct ownership of 2.68 Million shares of SEER, which is worth approximately $5.35 Million. The most recent transaction as insider was on Dec 09, 2025, when has been sold 1,438,057 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.68M
110.39% 3M change
86.33% 12M change
Total Value Held $5.35 Million

Omid Farokhzad Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 09 2025
BUY
Conversion of derivative security
-
1,438,057 Added 34.95%
2,676,287 Class A Common Stock
Nov 19 2025
SELL
Open market or private sale
$66,660 $1.97 p/Share
33,838 Reduced 2.66%
1,238,230 Class A Common Stock
Aug 20 2025
SELL
Open market or private sale
$69,343 $2.04 p/Share
33,992 Reduced 2.6%
1,272,068 Class A Common Stock
May 20 2025
SELL
Open market or private sale
$70,019 $2.08 p/Share
33,663 Reduced 2.51%
1,306,060 Class A Common Stock
Feb 18 2025
SELL
Payment of exercise price or tax liability
$203,536 $2.3 p/Share
88,494 Reduced 6.2%
1,339,723 Class A Common Stock
Feb 04 2025
SELL
Open market or private sale
$18,072 $2.24 p/Share
8,068 Reduced 0.56%
1,428,217 Class A Common Stock
Mar 07 2024
SELL
Open market or private sale
$107,299 $2.03 p/Share
52,857 Reduced 3.55%
1,436,285 Class A Common Stock
Feb 06 2024
BUY
Grant, award, or other acquisition
-
529,634 Added 26.24%
1,489,142 Class A Common Stock
Nov 02 2023
BUY
Exercise of conversion of derivative security
$6,070 $0.04 p/Share
151,764 Added 13.66%
959,508 Class A Common Stock
Aug 23 2023
BUY
Open market or private purchase
$98,000 $2.45 p/Share
40,000 Added 4.72%
807,744 Class A Common Stock
Feb 21 2023
SELL
Open market or private sale
$57,159 $4.13 p/Share
13,840 Reduced 1.77%
767,744 Class A Common Stock
Feb 15 2023
BUY
Grant, award, or other acquisition
-
402,000 Added 33.96%
781,584 Class A Common Stock
Feb 07 2023
SELL
Open market or private sale
$39,129 $4.67 p/Share
8,379 Reduced 2.16%
379,584 Class A Common Stock
Jan 17 2023
SELL
Open market or private sale
$24,576 $5.12 p/Share
4,800 Reduced 1.19%
399,123 Class A Common Stock
Nov 08 2022
BUY
Exercise of conversion of derivative security
$2,366 $0.04 p/Share
59,171 Added 13.09%
392,763 Class A Common Stock
Feb 08 2022
BUY
Grant, award, or other acquisition
-
155,000 Added 22.32%
539,487 Class A Common Stock
Feb 01 2021
SELL
Open market or private sale
$20,102,622 $64.15 p/Share
313,369 Reduced 51.3%
297,487 Class A Common Stock
Feb 01 2021
BUY
Grant, award, or other acquisition
-
87,000 Added 18.45%
384,487 Class A Common Stock
Jan 27 2021
BUY
Exercise of conversion of derivative security
$12,373 $0.04 p/Share
309,313 Added 34.45%
588,536 Class A Common Stock
Dec 03 2020
BUY
Grant, award, or other acquisition
-
22,320 Added 3.53%
610,856 Class A Common Stock

Also insider at

SNTI
Senti Biosciences, Inc. Healthcare
Director
OF

Omid Farokhzad

CEO AND CHAIR
South San Francisco, CA

Track Institutional and Insider Activities on SEER

Follow Seer, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SEER shares.

Notify only if

Insider Trading

Get notified when an Seer, Inc. insider buys or sells SEER shares.

Notify only if

News

Receive news related to Seer, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SEER